Point72 (DIFC)’s Legend Biotech LEGN Stock Holding History
Bought
Maintained
Sold
Other funds holding LEGN
HA
SCM
DM
B
Point72 (DIFC)'s LEGN Position: Q3 2025 in Review
Point72 (DIFC) sold out of Legend Biotech (LEGN) in Q3 2025, closing a stake of 1,914 shares — an estimated $67.9K sold.
Point72 (DIFC) first reported a position in LEGN in Q2 2025 and held it in 1 quarter. The position peaked at $67.9K in Q2 2025. 199 funds tracked by Wall St. Rank hold LEGN as of Q3 2025.
- Point72 (DIFC) reported no remaining Legend Biotech position as of Q3 2025 after selling out during the quarter.
- Point72 (DIFC) sold 1,914 Legend Biotech shares in Q3 2025, an estimated $67.9K.
- Point72 (DIFC) first reported a position in Legend Biotech in Q2 2025 and held it in 1 quarter.
- Point72 (DIFC)'s Legend Biotech position peaked at $67.9K in Q2 2025.
- 199 funds tracked by Wall St. Rank held Legend Biotech as of Q3 2025.
Based on Point72 (DIFC)'s 13F filing for Q3 2025, filed 14 Nov 2025.